Nourish Inc, a dietitian-led virtual metabolic care startup, raised $100 million in Series C funding.
Menlo Ventures led the investment round with participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners.
As part of the investment, Menlo Ventures’ partner J.P. Sanday will join the board.
Including the latest funding round, Nourish has raised a total of $215 million in funding to date.
Nourish will use the fresh funds to grow its clinical network, accelerate investment in AI agents for patients and providers, expand its metabolic clinic care model, and deepen partnerships with health plans, employers, and health systems.
According to the latest data provided by Nourish, nearly 200 million Americans live with nutrition-related chronic conditions, which are the leading drivers of the nearly $5 trillion spent on healthcare annually and more than one million preventable deaths each year. With fresh funds, Nourish aims to address these nutrition-related chronic health issues through an AI-native metabolic clinic built to drive behavior change and measurable outcomes.
Nourish is available to over 200 million Americans across all 50 states, through partnerships with the largest health plans, health systems, and employers.
“Chronic disease is the central failure of U.S. healthcare — nearly 200 million Americans affected, trillions spent, and outcomes that still don’t move. What Nourish has built in four years is remarkable: a care model that actually bends the cost curve, with 10,000 dietitians, deep payer relationships, and clinical outcomes patients stick with,” said J.P. Sanday, Partner at Menlo Ventures. “Most companies get one of those things right. Nourish has all of them. We’re proud to lead this round.”
Digital health companies, including virtual care startups, have secured more than $180 billion in funding to date, according to our recent Funding Database. More recently, Dehaze, a Germany–based healthtech startup developing a foundational AI model for chronic disease detection, raised €3.2 million in a Seed funding round.
In another deal, 9amHealth, an AI-enabled virtual specialty care startup, raised $26 million in a Series B funding round led by Define Ventures, with participation from SemperVirens VC, Catalio Capital Management, and NewHealth Ventures.